Skip to main content

Structural heart disease review of TAVR in low-risk patients: importance of lifetime management

Publication ,  Other
Moumneh, MB; Damluji, AA; Heslop, AW; Sherwood, MW
Published in: Frontiers in Cardiovascular Medicine
January 1, 2024

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Frontiers in Cardiovascular Medicine

DOI

EISSN

2297-055X

Publication Date

January 1, 2024

Volume

11

Related Subject Headings

  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Moumneh, M. B., Damluji, A. A., Heslop, A. W., & Sherwood, M. W. (2024). Structural heart disease review of TAVR in low-risk patients: importance of lifetime management. Frontiers in Cardiovascular Medicine. https://doi.org/10.3389/fcvm.2024.1362791
Moumneh, M. B., A. A. Damluji, A. W. Heslop, and M. W. Sherwood. “Structural heart disease review of TAVR in low-risk patients: importance of lifetime management.” Frontiers in Cardiovascular Medicine, January 1, 2024. https://doi.org/10.3389/fcvm.2024.1362791.
Moumneh MB, Damluji AA, Heslop AW, Sherwood MW. Structural heart disease review of TAVR in low-risk patients: importance of lifetime management. Vol. 11, Frontiers in Cardiovascular Medicine. 2024.
Moumneh, M. B., et al. “Structural heart disease review of TAVR in low-risk patients: importance of lifetime management.” Frontiers in Cardiovascular Medicine, vol. 11, 1 Jan. 2024. Scopus, doi:10.3389/fcvm.2024.1362791.
Moumneh MB, Damluji AA, Heslop AW, Sherwood MW. Structural heart disease review of TAVR in low-risk patients: importance of lifetime management. Frontiers in Cardiovascular Medicine. 2024.

Published In

Frontiers in Cardiovascular Medicine

DOI

EISSN

2297-055X

Publication Date

January 1, 2024

Volume

11

Related Subject Headings

  • 3201 Cardiovascular medicine and haematology